These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 14689878)
1. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy]. Kikuchi T; Miyata A; Fujii S; Kikuchi T Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878 [TBL] [Abstract][Full Text] [Related]
2. [Successful recovery of an acute myelogenous leukemia patient from a coma possibly due to leukoencephalopathy]. Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S Rinsho Ketsueki; 2003 Nov; 44(11):1090-4. PubMed ID: 14689873 [TBL] [Abstract][Full Text] [Related]
3. Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle. Ruutu T; Koivunen E; Nousiainen T; Pelliniemi TT; Almqvist A; Anttila P; Jantunen E; Koistinen P; Koponen A; Mikkola M; Oksanen K; Pulli T; Remes K; Sarkkinen R; Silvennoinen R; Timonen T; Vanhatalo S; Elonen E; Eur J Haematol; 2004 Jan; 72(1):38-44. PubMed ID: 14962261 [TBL] [Abstract][Full Text] [Related]
4. [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion]. Yoshida K; Kusumoto S; Sugahara Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Suzuki T; Hirashima K; Kayano H; Bessho M Rinsho Ketsueki; 2001 Aug; 42(8):644-9. PubMed ID: 11579505 [TBL] [Abstract][Full Text] [Related]
5. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia. Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346 [TBL] [Abstract][Full Text] [Related]
6. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808 [No Abstract] [Full Text] [Related]
7. Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction. Farah RA; Jalkh KS; Farhat HZ; Sayad PE; Kadri AM Blood Coagul Fibrinolysis; 2011 Mar; 22(2):140-3. PubMed ID: 21178585 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857 [TBL] [Abstract][Full Text] [Related]
9. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001. Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635 [TBL] [Abstract][Full Text] [Related]
10. Outcome of acute myeloid leukaemia in adults: a retrospective analysis. Saikia TK; Bakshi A; Bhagwat R; Tawde S; Nair R; Nair CN; Parikh PM Natl Med J India; 2005; 18(1):12-5. PubMed ID: 15835484 [TBL] [Abstract][Full Text] [Related]
11. [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy]. Yata K; Yamada O; Iwato K; Kyo T; Otsuki T; Nakanishi H; Suetsugu Y; Mikami M; Wada H; Yawata Y; Sugihara T Rinsho Ketsueki; 2002 Jan; 43(1):41-3. PubMed ID: 11868364 [TBL] [Abstract][Full Text] [Related]
12. [Acute monoblastic leukemia complicated by fatal splenic rupture following initiation of chemotherapy]. Borgeat A; Tran-Thang C; Bachmann F Schweiz Med Wochenschr; 1989 Feb; 119(7):227-9. PubMed ID: 2711160 [TBL] [Abstract][Full Text] [Related]
13. [Acute myelogenous leukemia developed at the 26th week of gestation]. Tashiro H; Umezawa K; Shirota M; Oka Y; Shirasaki R; Nishi R; Taguchi A; Akiyama N; Kawasugi K; Ayabe T; Shirafuji N Rinsho Ketsueki; 2011 Jan; 52(1):18-22. PubMed ID: 21378477 [TBL] [Abstract][Full Text] [Related]
14. Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes. Giles FJ; Kantarjian HM; Cortes JE; Faderl S; Verstovsek S; Thomas D; Garcia-Manero G; Wierda W; Ferrajoli A; Kornblau S; Mattiuzzi GN; Tsimberidou AM; Albitar M; O'Brien SM; Estey E Leuk Res; 2005 Jun; 29(6):649-52. PubMed ID: 15863204 [TBL] [Abstract][Full Text] [Related]
15. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study. HoĊowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133 [TBL] [Abstract][Full Text] [Related]
16. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience. Yavuz S; Paydas S; Disel U; Sahin B Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532 [TBL] [Abstract][Full Text] [Related]
17. [Intensive multi-drug chemotherapy for acute myeloid leukemia in a renal allograft recipient]. Yamasaki J; Hata T; Fuchigami K; Togami K; Honda M; Fukushima T; Miyazaki Y; Jinnai I; Kuriyama K; Tomonaga M Rinsho Ketsueki; 2003 Oct; 44(10):1015-9. PubMed ID: 14639948 [TBL] [Abstract][Full Text] [Related]
18. [Two cases of acute myelogenous leukemia complicated with fatal gastrointestinal tract bleeding after treatment with idarubicin and cytarabine]. Nagashima T; Izumi T; Muroi K; Miyasato A; Uchida M; Imagawa S; Komatsu N; Yoshida M; Hatake K; Miura Y; Ozawa K Gan To Kagaku Ryoho; 2000 Mar; 27(3):487-90. PubMed ID: 10740646 [TBL] [Abstract][Full Text] [Related]
19. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239 [TBL] [Abstract][Full Text] [Related]
20. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report]. He H; Li C; Han M Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]